Treatment Arm,N,CR/PR (%),TTR (days),OS median (days),Age (median),ECOG 0-1 (%)
Panitumumab + BSC,500,0.0,,200.0,63.0,86.8
BSC,500,0.0,,276.0,61.0,87.2
